The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-5-((4-((2-Hydroxy-1-phenylethyl)amino)-5-(3-(quinuclidin-4-yl)-1,2,4-oxadiazol-5-yl)pyrimidin-2-yl)amino)-3,3-dimethylisobenzofuran-1(3H)-one ID: ALA4780798
PubChem CID: 154697875
Max Phase: Preclinical
Molecular Formula: C31H33N7O4
Molecular Weight: 567.65
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC1(C)OC(=O)c2ccc(Nc3ncc(-c4nc(C56CCN(CC5)CC6)no4)c(N[C@H](CO)c4ccccc4)n3)cc21
Standard InChI: InChI=1S/C31H33N7O4/c1-30(2)23-16-20(8-9-21(23)27(40)41-30)33-29-32-17-22(25(35-29)34-24(18-39)19-6-4-3-5-7-19)26-36-28(37-42-26)31-10-13-38(14-11-31)15-12-31/h3-9,16-17,24,39H,10-15,18H2,1-2H3,(H2,32,33,34,35)/t24-/m1/s1
Standard InChI Key: RVFYCRCCTDEQQD-XMMPIXPASA-N
Molfile:
RDKit 2D
42 48 0 0 0 0 0 0 0 0999 V2000
16.3111 -6.5451 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3099 -7.3739 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0260 -7.7875 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.7438 -7.3734 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7409 -6.5414 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.0242 -6.1315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0218 -5.3050 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.7362 -4.8897 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7338 -4.0632 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4533 -5.3008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1678 -4.8854 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.4502 -3.6523 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4481 -2.8267 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7306 -2.4147 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0137 -2.8346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0193 -3.6588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.4602 -7.7855 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.1753 -7.3711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8883 -7.7837 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.8806 -6.1307 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1689 -6.5468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6020 -6.5426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6058 -7.3661 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3901 -7.6171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.8711 -6.9487 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.3840 -6.2847 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6359 -5.4976 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.1712 -8.4109 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1021 -8.0269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5998 -6.1322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5131 -5.3103 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.7047 -5.1387 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2916 -5.8546 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.8448 -6.4685 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.3684 -4.3838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8591 -3.7131 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5261 -2.9607 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7042 -2.8702 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.2164 -3.5386 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5505 -4.2974 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3841 -3.3811 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7871 -3.8486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
6 7 1 0
8 7 1 1
8 9 1 0
8 10 1 0
10 11 1 0
9 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 9 1 0
4 17 1 0
17 18 1 0
18 19 2 0
19 23 1 0
22 20 1 0
20 21 2 0
21 18 1 0
22 23 2 0
23 24 1 0
24 25 1 0
25 26 1 0
26 22 1 0
26 27 2 0
24 28 1 0
24 29 1 0
30 31 2 0
31 32 1 0
32 33 2 0
33 34 1 0
34 30 1 0
1 30 1 0
32 35 1 0
35 36 1 0
35 40 1 0
36 37 1 0
37 38 1 0
38 39 1 0
39 40 1 0
38 41 1 0
41 42 1 0
42 35 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 567.65Molecular Weight (Monoisotopic): 567.2594AlogP: 4.56#Rotatable Bonds: 8Polar Surface Area: 138.53Molecular Species: NEUTRALHBA: 11HBD: 3#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): 3#RO5 Violations (Lipinski): 2CX Acidic pKa: 11.25CX Basic pKa: 8.29CX LogP: 4.11CX LogD: 3.17Aromatic Rings: 4Heavy Atoms: 42QED Weighted: 0.26Np Likeness Score: -0.46
References 1. Degnan AP,Kumi GK,Allard CW,Araujo EV,Johnson WL,Zimmermann K,Pearce BC,Sheriff S,Futran A,Li X,Locke GA,You D,Morrison J,Parrish KE,Stromko C,Murtaza A,Liu J,Johnson BM,Vite GD,Wittman MD. (2021) Discovery of Orally Active Isofuranones as Potent, Selective Inhibitors of Hematopoetic Progenitor Kinase 1., 12 (3): [PMID:33732413 ] [10.1021/acsmedchemlett.0c00660 ]